PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for labs. Our team has curated content around Cannabis, Food Safety, and Life Sciences to drive the future of safe.

All too often in the conversation COVID-19 testing, two factors are lost: Pragmatism and Cost. Our Microarray platform can deliver highly effective Pooled Surveillance at a dramatically lower cost than individual testing and we are the proven alternative in Variant Identification—results in a fraction of the time and cost of NGS. The world is coming around to our way of thinking.

With the Cannabis and agriculture industry increasingly competitive for labs, growers and processors, new innovation and improved practices can be the difference in delivering ROI and outlasting competitors. PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for a cleaner Cannabis future. Here are the issues Cannabis faces now, with insights to help us all compete and win.

Even with COVID-19 dominating the headlines, Food Safety depends upon rapid, reliable detection of bacterial pathogens. With recalls costing the Food industry $100M per year or more, PathogenDx has rapidly adapted AOAC-Certified technology to speed up the clock on certainty and reliability to thwart Salmonella, Listeria and L. mono. Here’s a sampling of the issues driving our innovation.

PathogenDx delivers viral testing solutions for a new era dominated by the global pandemic, and is at the forefront of cannabis, and food testing. We are answering the challenge of individuals, communities and the moment itself, while monitoring the global conversation around pathogen testing to offer even more powerful solutions. Catch up on the latest news driving the future of safe.